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Abstract
Chytridiomycosis, caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), is an infectious disease that
causes population declines of many amphibians. Cutaneous bacteria isolated from redback salamanders, Plethodon
cinereus, and mountain yellow-legged frogs, Rana muscosa, inhibit the growth of Bd in vitro.I nt h i ss t u d y ,t h eb a c t e r i a l
community present on the skin of P. cinereus individuals was investigated to determine if it provides protection to
salamanders from the lethal and sub-lethal effects of chytridiomycosis. When the cutaneous bacterial community was
reduced prior to Bd exposure, salamanders experienced a significantly greater decrease in body mass, which is a
symptom of the disease, when compared to infected individuals with a normal bacterial community. In addition, a
greater proportion of infected individuals with a reduced bacterial community experienced limb-lifting, a behavior seen
only in infected individuals. Overall, these results demonstrate that the cutaneous bacterial community of P. cinereus
provides protection to the salamander from Bd and that alteration of this community can change disease resistance.
Therefore, symbiotic microbes associated with this species appear to be an important component of its innate skin
defenses.
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Introduction
Infectious diseases of wildlife are emerging at an increasing rate
and threaten global biodiversity [1]. The rapid emergence of
these diseases may be a result of the alteration of community
structures and relationships within ecosystems [1–3]. This
hypothesis is based primarily on communities of macroorganisms,
but alteration of the community structure of symbiotic microor-
ganisms may also pose a risk for disease emergence [4–6]. One
emerging infectious disease, chytridiomycosis, is a major factor
causing drastic declines and extinctions of amphibian species in
many parts of the world [7]. Chytridiomycosis is caused by the
chytrid fungus Batrachochytrium dendrobatidis (Bd), which colonizes
the skin of amphibian hosts [8]. There is no published evidence
suggesting that the adaptive immune system (e.g. antibody
production) is effective in controlling Bd. However for some
amphibian species, innate skin defenses, including the microbial
community of the skin and antimicrobial peptides secreted by the
granular glands, can provide defense against the pathogen [9,10].
In this study, we tested the hypothesis that alteration of
amphibians’ cutaneous microbial community can be associated
with disease outcome.
Persistence with Bd varies among and within amphibian
species [11–13] and has been associated with a species’
assemblage of antimicrobial peptides and cutaneous microbial
community [14–21]. In vitro studies and surveys have shown that
bacteria isolated from amphibi a ns k i np r o d u c es t r o n ga n t i - Bd
metabolites and these metabolites are present on the skin in high
enough concentrations to kill Bd zoospores and prevent disease
[16–20]. In addition, field surveys of populations of the
threatened frog Rana muscosa have shown that declining
populations are characterized by having a relatively low
proportion of individuals with anti-Bd skin bacteria. However,
populations coexisting with the pathogen have significantly
higher proportions of individuals with protective bacteria [21].
Bio-augmentation studies suggest that inoculating amphibians
with anti-Bd bacteria prior to infection prevents morbidity and
mortality by bacterial production of antifungal metabolites
[16,17]. The anti-Bd bacterial species Lysobacter gummosus isolated
from the salamanders Plethodon cinereus and Hemidactylium scutatum
produces the anti-Bd metabolite 2,4-diacetylphloroglucinol [19].
In addition, the bacterium Janthinobacterium lividum isolated from
P. cinereus, H. scutatum,a n dR. muscosa secretes the anti-Bd
compound violacein. This compound inhibits Bd growth at
relatively low concentrations (minimum inhibitory concentra-
tion equals 1.8 mM) [20].
The specific aim of this study was to determine if the bacterial
community on the skin of amphibians inhibits the growth of Bd in
vivo by testing whether salamanders with reduced skin bacteria
experience greater mortality and morbidity from Bd when
compared to individuals with a normal cutaneous microbiota.
The ability of cutaneous bacteria to inhibit the effects of Bd was
evaluated by measuring aspects of salamander health, such as
change in mass and survival, behavior, and the approximate
quantity of Bd zoospores present on the amphibians’ skin during
the course of the experiment.
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Study species
Plethodon cinereus is a terrestrial salamander with a geographic
range spanning across most of the northeastern United States,
southern Quebec, and the Maritime Provinces of Canada. This
species is highly abundant within its range. Their moist, nutrient-
rich skin helps support a diverse community of cutaneous bacteria
[22,23]. Bacterial isolates from the salamander inhibit the
amphibian fungal pathogens Mariannaea sp. [23] and Batrachochy-
trium dendrobatidis [10]. There is no evidence that P. cinereus is
affected by chytridiomycosis in nature, but this species can be
infected by Bd [17]. Therefore, this species was a good candidate
to determine if the cutaneous microbial community is responsible
for the apparent resistance of P. cinereus to chytridiomycosis.
Sampling and housing
Fifty-five adult salamanders were collected near Bother Knob in
the George Washington National Forest in Rockingham County,
Virginia. Cross contamination between samples was prevented by
using instant hand sanitizer containing ethyl alcohol between each
capture. The salamanders were brought into the laboratory within
24 hours where they were weighed and swabbed for the presence
of Bd. Swabs (MW100 fine-tip; Medical Wire & Equipment,
Corsham, Wiltshire, England) were drawn across the skin of the
ventral side 10 times and each of the lateral sides 10 times. Swabs
were frozen immediately at 280uC until further processing.
Salamanders were individually rinsed in sterile artificial pond
water [24] to remove transient bacteria from the skin before
swabbing [23]. Salamanders were housed in individual
1761267c m ( L 6W6H) sterile plastic containers lined with
sterile filter paper soaked with sterile artificial pond water.
Individuals were randomly placed at spots within incubators set
at a temperature of 17uC and a 12-hour light cycle, both of which
are representative of the species’ natural conditions. On a weekly
basis, salamanders were fed 10 fruit flies, which is an adequate
feeding regime to maintain weight, after which their housing was
cleaned and sterilized.
Experimental design
Each individual was assigned a number and placed in
treatments using a random numbers table generated from SAS
statistical software (SAS Institute Inc., Cary, North Carolina). Four
treatments (n=55) were used to test the overall hypothesis that the
microbial community is associated with disease outcome. The first
treatment (n=21) comprised individuals that had their cutaneous
bacteria reduced prior to being exposed to Bd (Bac2Bd+). The
second treatment (n=8) comprised individuals that had their
cutaneous bacteria reduced without being exposed to Bd
(Bac2Bd2). This treatment controlled for any possible effects
that the salamanders might have undergone as a result of the
removal of their microbiota. The third treatment (n=21)
comprised individuals that retained their cutaneous microbiota
in addition to being exposed to Bd (Bac+Bd+). Comparing this
treatment to the Bac2Bd+ treatment allowed us to determine if
the cutaneous microbiota inhibited the growth of Bd. The fourth
treatment (n=5) comprised individuals that retained their normal
community of bacteria while not being exposed to Bd (Bac+Bd2).
This treatment acted as a control for possible effects of the housing
and handling of the salamanders throughout the experiment.
Experimental treatments (Bd+) had a higher level of replication
than control treatments (Bd2) because we wanted the highest
statistical power for the comparison of most interest, i.e. does the
presence of microbiota reduce the effects of chytridiomycosis?
Bacteria removal
The treatments Bac2Bd+ and Bac2Bd2 were exposed to both
antibiotics and hydrogen peroxide to reduce the cutaneous
microbiota on each individual. In a preliminary experiment, it
was determined that three broad-spectrum antibiotics (9 mg/ml of
sulfamethazine, 12 mg/ml of cephalexin monohydrate, and 3 mg/
ml of trimethoprim) dissolved in artificial pond water in addition to
an exposure of 3% hydrogen peroxide significantly decreased the
mean number of morphologically distinct isolates (t-test, t=4.012,
d.f. =9, P,0.001). Hydrogen peroxide is also highly effective
against bacteria [25–27]. Salamanders were placed in individual
50 ml Falcon tubes (Becton Dickinson, Franklin Lakes, New Jersey)
with 15 ml of antibiotic solution for four hours. The Bac+Bd+
treatment and the Bac+Bd2 treatment were exposed to artificial
pond water for the same duration. After the antibiotic treatment,
individuals were allowed a 24-hour period of rest before being
exposed to a 3% percent hydrogen peroxide solution. Salamanders
were put in a 25 ml bath of hydrogen peroxide for 30 seconds and
then rinsed in artificial pond water. The Bac+Bd+ and Bac+Bd2
treatment groups were exposed to artificial pond water for the same
duration and then rinsed. After day 28, the Bac2Bd+ and
Bac2Bd2 treatment groups were exposed to an artificial pond
water solution containing 200 mg/ml of streptomycin and 100 mg/
ml of penicillin for seven days every other week. The antibiotic
solution was used to moisten the filter paper lining the containers
instead of artificial pond water as was used in the previous weeks.
This was done to reduce bacterial growth on the salamanders.
Penicillin and streptomycin do not inhibit Bd, as both antibiotics are
used in cultures of Bd to prevent bacterial growth [28]. The
treatments Bac+Bd+ and Bac+Bd2 continued to be exposed to
artificial pond water. Microbial richness was not sampled during the
experiment to minimize stress to the salamanders that would be
caused by additional swabbing. However, the use of identical
antibiotic bath protocols in the preliminary and main experiments
insuredthatmicrobial richnesswasreducedinthe main experiment.
Batrachochytrium dendrobatidis exposure
A strain of Bd, JEL 423, was obtained from J. E. Longcore
(University of Maine). The strain was isolated from the frog
Phyllomedusa lemur collected from El Cope ´, Panama on 17
December 2004 during a decline of amphibians due to Bd. This
isolate was chosen because it was representative of a lethal strain of
Bd. Culture maintenance and harvesting of zoospores followed
methods published by Rollins-Smith et al. [29]. Each salamander
in treatments Bac+Bd+ and Bac2Bd+ were exposed to approx-
imately 18.7610
6 zoospores suspended in 5 ml of artificial pond
water for 4 hours in 50 ml Falcon tubes. Tubes were turned every
30 minutes to ensure each individual was continually exposed to
the pathogen. This day was considered day 1 of the experiment.
Salamanders were then transferred to 8.56766.5 cm (L6W6H)
sterile plastic containers with the 5 ml Bd suspension for 24 hours.
Bac+Bd2 and Bac2Bd2 individuals were treated in a similar
fashion; however, they were placed in sterile artificial pond water.
Masses, behavior, and mortality
Masses were taken initially when the salamanders were brought
into the laboratory and at the conclusion of the experiment, day 55.
Before masses were measured, salamanders were individually
placed on sterile filter paper to remove excess moisture. Loss of
mass is a symptom of chytridiomycosisand hasbeen observed inBd-
infected P. cinereus individuals [17] as well as other amphibians
[30,31]. Mortality and behavioral changes (limb-lifting) were noted
bi-weekly during the course of the experiment. Limb-lifting is
defined as a salamander lifting one or more limbs off the substrate
Amphibian Innate Defenses
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was noted whether or not shed skin was present in the housing.
Batrachochytrium dendrobatidis detection
Salamanders were swabbed for Bd four times during the
experiment: initially and on days 14, 28, and 55. The same
technique for swabbing was used as previously described. All swabs
were frozen immediately at 280uC until further processing. DNA
was extracted from the swabs using 50 ul of PrepMan Ultra
(Applied Biosystems, Foster City, California), as described by Hyatt
et al. [32]. The real-time Taqman PCR assay protocol, as described
by Boyle et al. [33], with the addition of an internal control
procedure to detect the presence of PCR inhibitors [32] was used to
analyze the Bd swabs. Standards for the assay were obtained from
D. Boyle (CSIRO, Geelong, Australia). Samples were amplified in
triplicate with an Applied Biosystems 7500 real-time PCR system
(Applied Biosystems, Foster City, California). The experiment was
predetermined to last 55 days, which is representative of other Bd
infection studies [30,34–36], at which time all individuals were
euthanized with methane tricainesulfonate.
Statistical analyses
To determine whether removing bacteria affected body mass in
uninfected individuals, we compared mean proportion of body
mass lost in treatments Bac+Bd2 and Bac2Bd2 using a t-test.
Because changes in body mass were statistically indistinguishable
between these groups (t-test, t=0.948, d.f. =9, P=0.368), these
control treatments were pooled for the remainder of analyses [37].
Proportion of body mass lost by the control group and the two
experimental treatments, Bac+Bd+ and Bac2Bd+, was compared
using a one-way analysis of variance (ANOVA). Fisher’s least
significant difference was used to test the a priori hypothesis that the
Bac+Bd+ and Bac2Bd+ treatments differed from each other.
After initial body mass measurements were made, four salaman-
ders lost their tails and were removed from the mass analyses
because it was unclear how these individuals’ masses would change
over time had they not lost their tails. Limb-lifting behavioral data
and skin shedding data were analyzed with a Fisher’s exact test to
test the hypothesis that the proportion of individuals exhibiting
limb-lifting or skin shedding depended on treatment.
Results
Body mass and mortality
Bacterial removal did not affect change in body mass of
uninfected individuals (t-test, t=0.948, d.f. =9, P=0.368). Over
the course of the experiment, Bac2Bd+ salamanders lost three
times as much mean body mass as Bac+Bd+ salamanders and four
times as much as control individuals (ANOVA, F(2,48) =3.580,
P=0.036; Figure 1). The Bd strain JEL 423 did not cause
mortality, as all salamanders were still living at the end of the
experiment.
Behavior and skin shedding
Individuals exposed to Bd displayed signs of infection, such as
excessive skin shedding and raising their limbs off the substrate.
During the course of the experiment, a higher proportion of Bd
exposed individuals shed skin (Fisher’s exact test, d.f. =1,
P=0.035) and lifted limbs (Fisher’s exact test, d.f. =1, P,0.001)
than control salamanders. For individuals exposed to Bd,a n
equivalent proportion of individuals shed skin in treatments
Bac2Bd+ and Bac+Bd+ (Fisher’s exact test, d.f. =1, P=0.253).
For the two treatment groups exposed to Bd, skin shedding peaked
during week two of the experiment and declined over the
remainder of the study (Figure 2). Limb-lifting behavior peaked
during week one, declined until week four (Figure 3), and was not
observed again. During the course of the experiment, more
individuals of the treatment Bac2Bd+ held their limbs off the
substrate than Bac+Bd+ individuals (Fisher’s exact test, d.f. =1,
P=0.031).
Infection level
No zoospore DNA was detected on the skin before the
salamanders were exposed to Bd. Throughout the experiment,
mean numbers of zoospore equivalents as detected by real-time
Taqman PCR were low for all individuals exposed to Bd. On day
Figure 1. Proportion of body mass lost over a period of 55 days for treatments Bac2Bd+ (n=20), Bac+Bd+ (n=20), and controls
(Bac2Bd2 and Bac+Bd2, n=11). Error bars represent 61 standard error.
doi:10.1371/journal.pone.0010957.g001
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an average of 0.3960.79 (SD) and 0.49160.56 (SD) zoospore
equivalents, respectively, whereas individuals in the Bd2 control
treatment had no detectable zoospore equivalents. On days 28 and
55 of the experiment, all salamanders tested negative for Bd.
Therefore, all salamanders were able to clear their infections by
day 28, as determined by real-time Taqman PCR. The low levels
of Bd detected at day 14 suggest that salamanders were able to
clear infections rapidly even with a reduced skin microbiota.
Discussion
This study demonstrates that the community of cutaneous
bacteria on P. cinereus is an important factor preventing weight loss,
a non-lethal symptom of chytridiomycosis, of infected individuals
and thus is a component of the innate skin defenses. The lack of
mortality and loss of infection seen in this experiment, even among
individuals with their bacterial community reduced, is likely due to
components of the innate defense system other than anti-Bd
bacteria, such as antimicrobial peptide secretions and behavioral
changes. Antimicrobial peptides have been found on a number of
amphibian species and can inhibit Bd in vitro [9].
The low number of zoospore equivalents found on salamanders
suggests that the infection subsided before the salamanders’ skins
were first assayed on day 14. In a comparable infection experiment
with P. cinereus, similar infection intensities (weighted mean=7.72
zoospore equivalents per infected individual) were found at day 14,
suggesting that the pathogen is quickly cleared from the skin in this
Figure 2. Proportion of individuals in treatments Bac+Bd+ (n=21), Bac2Bd+ (n=21), and control (n=13) that shed skin each week.
doi:10.1371/journal.pone.0010957.g002
Figure 3. Proportion of individuals in treatments Bac+Bd+ (n=21), Bac2Bd+ (n=21), and control (n=13) that lifted their limbs off
substrate for at least five minutes each week.
doi:10.1371/journal.pone.0010957.g003
Amphibian Innate Defenses
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e10957species of salamander [17]. In that study, histological examination
of shed skins confirmed the presence of zoosporangia even though
infection intensities were low. The observation that skin shedding
and limb-lifting rates were greatest in the first two weeks and
decreased thereafter provides additional evidence that an infection
occurred early in the experiment and was quickly cleared. The
difference in the change in body mass evident after 55 days
suggests that individuals in the Bac2Bd+ treatment had a
reduction in mass caused by infection prior to day 14, when the
amount of Bd detected was low, and the reduction in mass was
retained throughout the experiment. Individuals in the Bac+Bd+
treatment and control individuals maintained their body mass
throughout the experiment. Interestingly, limb-lifting behavior has
not been previously described for this species and its cause and
function are unknown, but it might minimize transmission of Bd
from moist soils in nature. The strict randomization included in
the experimental design strongly suggests that significant differ-
ences in weight loss and limb-lifting behavior were due to
treatment differences [38].
The beneficial effect provided by the bacterial community in this
experiment may be attributed to a mutualism between the host and
itsmicrobes, whichgain nutrients and substrate from theamphibian
host. Similar mutualisms are seen in other host-symbiont models.
For example, the beetle Dendroctonus frontalis, the wasp Philanthus
triangulum, the leaf-cutter ant (Attini: Formicidae), and the lobster
Homarus americanus all display mutualistic relationships with
microorganisms. In all of these cases, the host is protected from a
pathogenic fungus by a bacterial symbiont [39–42]. In these species,
the bacterial symbiont produces antibiotic metabolites that inhibit
the invading pathogen. For example, chemical analysis of a
mutualistic actinomycetous bacterium isolated from its host, D.
frontalis, has revealed that fungal infestation of the host is prevented
by secretion of a polyene peroxide [42].
The protective effect provided by the bacterial community of P.
cinereus may be a result of multiple ecological interactions with the
invading zoospores. This beneficial community could prevent the
colonization and inhibit growth of invading zoospores in at least
three ways. First, the number of potential sites that zoospores can
colonize is reduced by the presence of resident microbes. The
ability of resident bacteria to prevent invading microorganisms by
blocking adhesion sites has been demonstrated in past studies
[43,44]. Second, many bacteria have the ability to alter the
microenvironment that they inhabit through secretory products
[45,46]. If the microenvironment of amphibian skin, such as its
pH, is altered in a way that zoospores could not survive, this could
prevent the colonization of Bd. Third, many bacterial species
secrete antimicrobial compounds that directly kill other microor-
ganisms. These antimicrobial compounds include products such as
enzymes, bacteriocins, fatty acids, and hydrogen peroxide [47,48].
Bacteria isolated from amphibians secrete secondary metabolites
that inhibit the growth of Bd in vitro [19,20]. For example, the
bacterial species Janthinobacterium lividum isolated from the amphib-
ian species P. cinereus, Hemidactylium scutatum, and R. muscosa secretes
violacein and indole-3-carboxaldehyde. These compounds strong-
ly inhibit the growth of Bd at low concentrations [20].
As suggested by this study, skin bacteria are not the only factor
preventing chytridiomycosis. There are multiple aspects of an
amphibian’s innate defenses, which include sloughing of the skin
and glandular secretions. In this study, Bd affected the rate of skin
shedding. Sloughing of skin is a symptom of chytridiomycosis [49].
However, in the case of P. cinereus, this response may function as a
way for the salamander to reduce the zoospore load and prevent
severe infection. Bd resides entirely in the outer cell layers of the
epidermis [50]. When Bd colonizes amphibian skin, it is
hypothesized that a germ tube grows into the lower cell layers of
the epidermis through which its intracellular contents are inserted
into an epidermal cell [51]. The chytrid develops while normal
renewal of skin layers occurs such that when zoosporangia are
mature, they are at the outermost layer of amphibian skin [50].
Accelerating the rate at which skin is replaced could result in
shedding of Bd before it has matured, thereby preventing the release
ofzoosporesonthe host.Acceleratedsheddingofthe skin maybean
effective response of amphibians in reducing the pathogen load on
the skin. However, no difference in the proportion of individuals
that shed their skins between Bac2Bd+ and Bac+Bd+ treatments
was detected, meaning that skin shedding cannot explain the
difference in weight loss observed between these treatments.
This study provides evidence that the cutaneous bacterial
community is an important component of the innate skin defenses
of P. cinereus that prevented weight loss associated with chytridiomy-
cosis. Other defensive mechanisms, such as antimicrobial peptides,
behaviors, and skin shedding rates have been shown to be important
or are likely to be important in patterns of species-specific survival in
response to chytridiomycosis. However, these mechanisms are not
amenable to manipulation as a management tool in conservation.
Manipulation of anti-Bd bacteria is a promising method that has the
potential to allow re-introductions of amphibians from survival
assurance (captive breeding) colonies into nature as well as to slow
successful dispersal of chytridiomycosis in nature. In a laboratory
experiment, bio-augmentation of the skins of mountain yellow-
legged frogs, R. muscosa,w i t ha n t i - Bd bacteria prevented morbidity
and mortality due to Bd seen in individuals not treated with anti-Bd
bacteria [16]. Taken together, the ‘‘bacteria removal’’ approach
used in this study and the ‘‘bacterial addition’’ approach employed
with R. muscosa provide evidence that alterations of microbial
community structure can either enhance or decrease amphibian
health. Further research is needed to determine the efficacy of
bacterial manipulations as a means of preventing further declines of
amphibian species due to chytridiomycosis.
Acknowledgments
We thank J. Kastendiek, J. Herrick, and L. Belden for valuable comments
on the manuscript, J. Walke and B. Lam for helpful assistance in the
laboratory, A. Hyatt for providing qPCR materials, and I. Knight for
performing qPCR. Permits to collect were provided by the Virginia
Department of Game and Inland Fisheries and animal care protocols were
approved by JMU’s Animal Care and Use Committee.
Author Contributions
Conceived and designed the experiments: MHB RNH. Performed the
experiments: MHB RNH. Analyzed the data: MHB RNH. Contributed
reagents/materials/analysis tools: MHB RNH. Wrote the paper: MHB
RNH.
References
1. Daszak P, Cunningham AA, Hyatt AD (2000) Emerging infectious diseases
of wildlife: threats to biodiversity and human health. Science 287: 443–
449.
2. LoGiudice K, Ostfeld RS, Schmidt KA, Keesing F (2003) The ecology of
infectious disease: effects of host diversity and community composition on Lyme
disease risk. Proc Natl Acad Sci USA100: 567–571.
3. Keesing F, Holt RD, Ostfeld RS (2006) Effects of species diversity on disease
risk. Ecol Lett 9: 485–498.
4. Belden LK, Harris RN (2007) Infectious diseases in wildlife: the community
ecology context. Front Ecol Environ 5: 533–539.
5. Webster NS, Cobb RE, Negri AP (2008) Temperature thresholds for bacterial
symbiosis with a sponge. ISME J 2: 830–842.
Amphibian Innate Defenses
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e109576. Ainsworth TD, Hoegh-Guldberg O (2009) Bacterial communities closely
associated with coral tissues vary under experimental and natural reef conditions
and thermal stress. Aquat Biol 4: 289–296.
7. Skerratt LF, Berger L, Speare R, Cashins S, McDonald KR, et al. (2007) Spread
of chytridiomycosis has caused the rapid global decline and extinction of frogs.
EcoHealth 4: 125–134.
8. Berger L, Speare R, Daszak P, Green DE, Cunningham AA, et al. (1998)
Chytridiomycosis causes amphibian mortality associated with population
declines in the rain forests of Australia and Central America. Proc Natl Acad
Sci USA 95: 9031–9036.
9. Rollins-Smith LA, Conlon JM (2005) Antimicrobial peptide defenses against
chytridiomycosis, an emerging infectious disease of amphibian populations. Dev
Comp Immunol 29: 589–598.
10. Harris RN, James TY, Lauer A, Simon MA, Patel A (2006) Amphibian
pathogen Batrachochytrium dendrobatidis is inhibited by the cutaneous bacteria of
amphibian species. EcoHealth 3: 53–56.
11. Lips KR, Reeve JD, Witters LR (2003) Ecological traits predicting amphibian
population declines in Central America. Conserv Biol 17: 1078–1088.
12. Retallick RW, Mccallum H, Speare R (2004) Endemic infection of the
amphibian chytrid fungus in a frog community post-decline. PLoS Biol 2: e351.
doi:10.1371/journal.pbio.0020351.
13. Woodhams DC, Alford RA (2005) Ecology of chytridiomycosis in rainforest
stream frog assemblages of tropical Queensland. Conserv Biol 19: 1449–1459.
14. Woodhams DC, Voyles J, Lips KR, Carey C, Rollins-Smith LA (2006) Predicted
disease susceptibility in a Panamanian amphibian assemblage based on skin
peptide defenses. J Wildl Dis 42: 207–218.
15. Woodhams DC, Rollins-Smith LA, Carey C, Reinert L, Tyler MJ, et al. (2006)
Population trends associated with skin peptide defenses against chytridiomycosis
in Australian frogs. Oecologia 146: 531–540.
16. Harris RN, Brucker RM, Walke JB, Becker MH, Woodhams DC, et al. (2009)
Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin
fungus. ISME J 3: 818–824.
17. Harris RN, Lauer A, Simon MA, Banning JL, Alford RA (2009) Addition of
antifungal skin bacteria to amphibians ameliorates the effects of chytridiomy-
cosis. Dis Aquat Org 83: 11–16.
18. Becker MH, Brucker RM, Schwantes CR, Harris RN, Minbiole KPC (2009)
The bacterially-produced metabolite violacein is associated with survival in
amphibians infected with a lethal disease. Appl Environ Microb 75: 6635–6638.
19. Brucker RM, Baylor CM, Walters RL, Lauer A, Harris RN, et al. (2008) The
identification of 2,4-diacetylphloroglucinol as an antifungal metabolite produced
by cutaneous bacteria of the salamander Plethodon cinereus. J Chem Ecol 34:
39–43.
20. Brucker RM, Harris RN, Schwantes CR, Gallaher TN, Flaherty DC, et al.
(2008) Amphibian chemical defense: antifungal metabolites of the microsym-
biont Janthinobacterium lividum on the salamander Plethodon cinereus. J Chem Ecol
34: 1422–1429.
21. Woodhams DC, Vredenburg VT, Simon MA, Billheimer D, Shakhtour B, et al.
(2007) Symbiotic bacteria contribute to innate immune defenses of the
threatened mountain yellow-legged frog, Rana muscosa. Biol Conserv 138:
390–398.
22. Austin RM (2000) Cutaneous microbial flora and antibiosis in Plethodon ventralis.
In: The biology of plethodontid salamanders, Bruce RC, Jaeger RG, Houck LD, eds.
New York: Kluwer Academic/Plenum Publishers. pp 451–462.
23. Lauer A, Simon MA, Banning JL, Andre ´ E, Duncan K, et al. (2007) Common
cutaneous bacteria from the eastern red-backed salamander can inhibit
pathogenic fungi. Copeia 2007: 630–640.
24. Wyngaard GA, Chinnappa CC (1982) General biology and cytology of
cyc1opoids. In: Developmental biology of freshwater invertebrates, Harrison FN,
Cowden RR, eds. New York: Alan R. Liss, Inc.. pp 485–533.
25. Lumsden JS, Ostland VE, Ferguson HW (1998) Use of hydrogen peroxide to
treat experimentally induced bacterial gill disease in rainbow trout. J Aquat
Anim Health 10: 230–240.
26. Rach JJ, Schleis SM, Gaikowski M, Johnson A (2003) Efficacy of hydrogen
peroxide in controlling mortality associated with external columnaris on walleye
and channel catfish fingerlings. N Am J Aquacult 65: 300–305.
27. Russo R, Curtis EW, Yanong RPE (2007) Preliminary investigations of
hydrogen peroxide treatment of selected ornamental fishes and efficacy against
external bacteria and parasites in green swordtails. J Aquat Anim Health 19:
121–127.
28. Woodhams DC, Alford RA, Briggs CJ, Johnson M, Rollins-Smith LA (2008)
Life-history trade-offs influence disease in changing climates: strategies of an
amphibian pathogen. Ecology 89: 1627–1639.
29. Rollins-Smith LA, Carey C, Longcore JE, Doersam JK, Boutte A, et al. (2002)
Activity of antimicrobial skin peptides from ranid frogs against Batrachochytrium
dendrobatidis, the chytrid fungus associated with global amphibian declines. Dev
Comp Immunol 26: 471–479.
30. Retallick RW, Miera V (2007) Strain differences in the amphibian chytrid
Batrachochytrium dendrobatidis and non-permanent, sub-lethal effects of infection.
Dis Aquat Org 75: 201–207.
31. Davidson EW, Parris M, Collins JP, Longcore JE, Pessier AP, et al. (2003)
Pathogenicity and transmission of chytridiomycosis in tiger salamanders
(Ambylostoma tigrinum). Copeia 3: 601–607.
32. Hyatt AD, Boyle DG, Olsen V, Boyle DB, Berger L, et al. (2007) Diagnostic
assays and sampling protocols for the detection of Batrachochytrium dendrobatidis.
Dis Aquat Org 73: 175–192.
33. Boyle DG, Boyle DB, Olsen V, Morgan J, Hyatt AD (2004) Rapid quantitative
detection of chytridiomycosis (Batrachochytrium dendrobatidis) in amphibian samples
using real-time Taqman PCR assay. Dis Aquat Org 60: 141–148.
34. Carey C, Bruzgul JE, Livo LJ, Walling ML, Kuehl KA, et al. (2006)
Experimental exposures of boreal toads (Bufo boreas) to a pathogenic chytrid
fungus (Batrachochytrium dendrobatidis). Ecohealth 3: 5–21.
35. Andre SE, Parker J, Briggs CJ (2008) Effect of temperature on host response to
Batrachochytrium dendrobatidis infection in the mountain yellow-legged frog (Rana
muscosa). J Wildl Dis 44: 716–720.
36. Murphy PJ, St-Hilaire S, Bruer S, Corn PS, Peterson CR (2009) Distribution
and pathogenicity of Batrachochytrium dendrobatidis in boreal toads from the Grand
Teton area of western Wyoming. Ecohealth 6: 109–120.
37. Sokal RR, Rohlf FJ (1995) Biometry: the principles and practice of statistics in
biological research, 3
rd edition, New York: W. H. Freeman and Co.
38. Blaustein AR, Alford RA, Harris RN (2009) The value of well-designed
experiments in studying diseases with special reference to amphibians. Ecohealth
DOI: 10.1007/s10393-009-0266-5.
39. Gil-Turnes MS, Fenical W (1992) Embryos of Homarus americanus are protected
by epibiotic bacteria. Biol Bull 182: 105–108.
40. Currie CR, Scott JA, Summerbell RC, Malloch D (1999) Fungus-growing ants
use antibiotic-producing bacteria to control garden parasites. Nature 398:
701–704.
41. Kaltenpoth M, Gottler W, Herzner G, Strohm E (2005) Symbiotic bacteria
protect wasp larvae from fungal infestation. Curr Biol 15: 475–479.
42. Scott JJ, Oh DC, Yuceer MC, Klepzig KD, Clardy J, et al. (2008) Bacterial
protection of beetle-fungus mutualism. Science 322: 63.
43. Kennedy MJ, Volz PA (1985) Ecology of Candida albicans gut colonization:
inhibition of Candida adhesion, colonization, and dissemination from the
gastrointestinal tract by bacterial antagonism. Infect Immun 49: 654–663.
44. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW (1985) Competitive
exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole
cells and cell wall fragments. Infect Immun 47: 84–89.
45. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA (1999) Acid
production by vaginal flora in vitro is consistent with the rate and extent of
vaginal acidification. Infect Immun 67: 5170–5175.
46. Matousek JL, Campbell LK (2002) A comparative review of cutaneous pH. Vet
Dermatol 13: 293–300.
47. Brook I (1999) Bacterial interference. Cr Rev Microbiol 25: 155–172.
48. Wilson M (2005) Role of the indigenous microbiota in maintaining human
health. In: Microbial inhabitants of humans: their ecology and role in health and disease,
New York: Cambridge University Press. pp 375–394.
49. Pessier AP (2002) An overview of amphibian skin disease. Semin Avian Exot Pet
11: 162–174.
50. Berger L, Hyatt AD, Speare R, Longcore JE (2005) Life cycle stages of the
amphibian chytrid Batrachochytrium dendrobatidis. Dis Aquat Org 68: 51–63.
51. Longcore JE, Pessier AP, Nichols DK (1999) Batrachochytrium dendrobatidis gen. et
sp. nov., a chytrid pathogenic to amphibians. Mycologia 91: 219–227.
Amphibian Innate Defenses
PLoS ONE | www.plosone.org 6 June 2010 | Volume 5 | Issue 6 | e10957